Wave Life Sciences (WVE) EPS (Weighted Average and Diluted) (2021 - 2025)
Wave Life Sciences (WVE) has disclosed EPS (Weighted Average and Diluted) for 5 consecutive years, with -$0.29 as the latest value for Q4 2025.
- For the quarter ending Q4 2025, EPS (Weighted Average and Diluted) fell 207.41% year-over-year to -$0.29, compared with a TTM value of -$1.21 through Dec 2025, down 72.86%, and an annual FY2025 reading of -$1.21, down 72.86% over the prior year.
- EPS (Weighted Average and Diluted) was -$0.29 for Q4 2025 at Wave Life Sciences, up from -$0.32 in the prior quarter.
- Across five years, EPS (Weighted Average and Diluted) topped out at $0.27 in Q4 2024 and bottomed at -$0.78 in Q2 2021.
- Average EPS (Weighted Average and Diluted) over 5 years is -$0.32, with a median of -$0.29 recorded in 2025.
- Peak annual rise in EPS (Weighted Average and Diluted) hit 280.0% in 2024, while the deepest fall reached 771.43% in 2024.
- Year by year, EPS (Weighted Average and Diluted) stood at -$0.61 in 2021, then rose by 26.23% to -$0.45 in 2022, then soared by 66.67% to -$0.15 in 2023, then skyrocketed by 280.0% to $0.27 in 2024, then tumbled by 207.41% to -$0.29 in 2025.
- Business Quant data shows EPS (Weighted Average and Diluted) for WVE at -$0.29 in Q4 2025, -$0.32 in Q3 2025, and -$0.31 in Q2 2025.